A drug used to treat breast cancer that has spread to other parts of the body and has already been treated with an anthracycline and a taxane (types of anticancer drugs). It is also used to treat liposarcoma (a type of soft tissue sarcoma) that cannot be removed by surgery or has spread to other parts of the body. It is used in patients whose cancer has already been treated with an anthracycline. It is also being studied in the treatment of other types of cancer. E7389 blocks cell growth by stopping cell division and may kill cancer cells. It is a type of antitubulin agent. Also called eribulin mesylate and Halaven.
For More: http://www.sciaeon.org/cancer-biology-and-clinical-oncology/home
Manuscript Submissions: http://www.sciaeon.org/cancer-biology-and-clinical-oncology/submit-paper
Contact: cancerbiology@sciaeonopenaccess.com
Journal of Cancer Biology and Clinical Oncology 